These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of atypical neuroleptics in child and adolescent psychiatry. Toren P; Laor N; Weizman A J Clin Psychiatry; 1998 Dec; 59(12):644-56. PubMed ID: 9921698 [TBL] [Abstract][Full Text] [Related]
7. [Atypical neuroleptics in the child and adolescent]. Naja WJ; Reneric JP; Bouvard MP Encephale; 1998; 24(4):378-85. PubMed ID: 9809243 [TBL] [Abstract][Full Text] [Related]
8. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
9. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293 [TBL] [Abstract][Full Text] [Related]
10. Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients. Pogge DL; Singer MB; Harvey PD J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):901-12. PubMed ID: 16379510 [TBL] [Abstract][Full Text] [Related]
11. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
12. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. Ratzoni G; Gothelf D; Brand-Gothelf A; Reidman J; Kikinzon L; Gal G; Phillip M; Apter A; Weizman R J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):337-43. PubMed ID: 11886029 [TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication use in children and adolescents in an inpatient setting. Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516 [TBL] [Abstract][Full Text] [Related]
16. Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study. Strous RD; Kupchik M; Roitman S; Schwartz S; Gonen N; Mester R; Weizman A; Spivak B Hum Psychopharmacol; 2006 Jun; 21(4):235-43. PubMed ID: 16783815 [TBL] [Abstract][Full Text] [Related]
17. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. István S; Agoston T; Tamás T; Zoltán J Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029 [TBL] [Abstract][Full Text] [Related]
18. Weight gain: side effect of atypical neuroleptics? Wetterling T; Müssigbrodt HE J Clin Psychopharmacol; 1999 Aug; 19(4):316-21. PubMed ID: 10440458 [TBL] [Abstract][Full Text] [Related]
19. [A case of leukopenia in treatment with risperidone in an adolescent]. Etain B; Roubaud L; Le Heuzey MF; Mouren Simeoni MC Encephale; 2000; 26(5):81-4. PubMed ID: 11192809 [TBL] [Abstract][Full Text] [Related]
20. Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients. Ruaño G; Goethe JW; Caley C; Woolley S; Holford TR; Kocherla M; Windemuth A; de Leon J Mol Psychiatry; 2007 May; 12(5):474-82. PubMed ID: 17199131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]